TCL Archive ODAC Meeting: Further Restrictions Likely On ESA Use; Changes Advocated by ODAC May Cut Market By 40-50 Percent. March 21, 2008
TCL Archive Oxaliplatin Regimen May Beat Standard For Advanced Colorectal Cancer, NCI Says May 3, 2002